KROS NASDAQ
Keros Therapeutics, Inc.
1W: +2.1%
1M: -1.9%
3M: -30.7%
YTD: -39.5%
1Y: -20.6%
3Y: -75.8%
5Y: -77.0%
$11.19
-0.03 (-0.27%)
Weekly Expected Move ±6.9%
$9
$10
$10
$11
$12
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026188
Institutions Holding
-8 vs prior
43.1%
Ownership
-69.78%
24
New
41
Increased
106
Reduced
59
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | BIENAIME JEAN JACQUES | director | P-Purchase | 1,000 | $10.58 | $11K | Filing |
| 2026-04-15 | BIENAIME JEAN JACQUES | director | P-Purchase | 1,000 | $11.70 | $12K | Filing |
| 2026-02-19 | Seehra Jasbir | officer: chief executive officer | S-Sale | 7,015 | $16.17 | $113K | Filing |
| 2026-02-18 | Lerner Lorena Raquel | officer: chief science officer | S-Sale | 3,873 | $16.35 | $63K | Filing |
| 2026-02-18 | Regnante Keith | officer: chief financial officer | S-Sale | 4,739 | $16.35 | $77K | Filing |
| 2026-02-18 | Cho Esther | officer: svp, general counsel | S-Sale | 4,745 | $16.35 | $78K | Filing |
| 2025-11-21 | OrbiMed Capital GP VII LLC | director | D-Sale to Issuer | 140,057 | $17.75 | $2.5M | Filing |
| 2025-11-21 | GORDON CARL L | director | D-Sale to Issuer | 74,465 | $17.75 | $1.3M | Filing |
| 2025-11-21 | ORBIMED ADVISORS LLC | director | D-Sale to Issuer | 140,057 | $17.75 | $2.5M | Filing |
| 2025-11-21 | OrbiMed Genesis GP LLC | director | D-Sale to Issuer | 140,057 | $17.75 | $2.5M | Filing |
| 2025-11-21 | ORBIMED ADVISORS LLC | director | D-Sale to Issuer | 74,465 | $17.75 | $1.3M | Filing |
| 2025-11-21 | OrbiMed Capital GP VII LLC | director | D-Sale to Issuer | 74,465 | $17.75 | $1.3M | Filing |
| 2025-11-21 | OrbiMed Genesis GP LLC | director | D-Sale to Issuer | 74,465 | $17.75 | $1.3M | Filing |
| 2025-11-21 | Knowles Julius | director | D-Sale to Issuer | 191,527 | $17.75 | $3.4M | Filing |
| 2025-11-21 | Knowles Julius | director | D-Sale to Issuer | 130,494 | $17.75 | $2.3M | Filing |
| 2025-11-21 | GORDON CARL L | director | D-Sale to Issuer | 140,057 | $17.75 | $2.5M | Filing |
| 2025-10-15 | Pontifax Late Stage Fund L.P. | 10% owner | S-Sale | 2,284,612 | $17.75 | $40.6M | Filing |
| 2025-10-15 | Pontifax Late Stage GP Ltd. | 10% owner | S-Sale | 2,284,612 | $17.75 | $40.6M | Filing |
| 2025-10-15 | Nussbaum Ran | director | S-Sale | 2,284,612 | $17.75 | $40.6M | Filing |
| 2025-10-15 | ADAR1 Partners, LP | 10% owner | S-Sale | 254,669 | $17.75 | $4.5M | Filing |
| 2025-10-15 | ADAR1 Capital Management, LLC | 10% owner | S-Sale | 743,358 | $17.75 | $13.2M | Filing |
| 2025-10-15 | Schneeberger Daniel | 10% owner | S-Sale | 254,669 | $17.75 | $4.5M | Filing |
| 2025-10-15 | ADAR1 Capital Management GP, LLC | 10% owner | S-Sale | 254,669 | $17.75 | $4.5M | Filing |
| 2025-10-15 | ADAR1 Partners, LP | 10% owner | S-Sale | 4,391,237 | $17.75 | $77.9M | Filing |
| 2025-10-15 | ADAR1 Capital Management, LLC | 10% owner | S-Sale | 4,391,237 | $17.75 | $77.9M | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,411,793 | $27M | +121,261 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 831,421 | $9M | +831,421 | 2026-03-31 | Filing |
| ORBIMED ADVISORS LLC | 759,155 | $8M | -45,057 | 2026-03-31 | Filing |
| Qube Research & Technologies Ltd | 724,926 | $8M | -58,992 | 2026-03-31 | Filing |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 706,071 | $8M | -62,354 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 682,043 | $8M | +682,043 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 681,460 | $8M | +46,252 | 2026-03-31 | Filing |
| Madison Avenue Partners, LP | 626,583 | $7M | -197,124 | 2026-03-31 | Filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 590,249 | $7M | -744,267 | 2026-03-31 | Filing |
| STATE STREET CORP | 561,730 | $6M | -514,263 | 2026-03-31 | Filing |
| RENAISSANCE TECHNOLOGIES LLC | 453,482 | $5M | -138,204 | 2026-03-31 | Filing |
| AQR CAPITAL MANAGEMENT LLC | 406,563 | $4M | +226,020 | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 321,360 | $4M | +263,347 | 2026-03-31 | Filing |
| Nuveen, LLC | 262,075 | $3M | +198,978 | 2026-03-31 | Filing |
| NORTHERN TRUST CORP | 254,187 | $3M | +3,616 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 224,479 | $2M | -366,038 | 2026-03-31 | Filing |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 195,017 | $2M | +134,939 | 2026-03-31 | Filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 179,952 | $2M | -6,827 | 2026-03-31 | Filing |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 172,196 | $2M | +138,425 | 2026-03-31 | Filing |
| Y-Intercept (Hong Kong) Ltd | 164,483 | $2M | +47,122 | 2026-03-31 | Filing |